Transdermal Drug Delivery Systems: Methods for Enhancing Skin Permeability and Their Evaluation
Pharmaceutics · 20.07.2025 · 17 (7) · 936
DOI: 10.3390/pharmaceutics17070936 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 20.07.2025. Verfasst von Elena O Bakhrushina und 10 weiteren Autor:innen. Beteiligte Einrichtung: A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Transdermal drug delivery (TDD) is an increasingly important non-invasive method for administering active pharmaceutical ingredients (APIs) through the skin barrier, offering advantages such as improved therapeutic efficacy and reduced systemic side effects. As demand increases for patient-friendly and minimally invasive treatment options, TDD has attracted substantial attention in research and clinical practice. This review summarizes recent advances enhancing skin permeability through chemical enhancers (e.g., ethanol, fatty acids, terpenes), physical (e.g., iontophoresis, microneedles, sonophoresis), and nanotechnological methods (e.g., liposomes, ethosomes, solid lipid nanoparticles, and transferosomes). A comprehensive literature analysis, including scientific publications, regulatory guidelines, and patents, was conducted to identify innovative methods and materials used to overcome the barrier properties of the stratum corneum. Special emphasis was placed on in vitro, ex vivo, and in vivo evaluation techniques for such as Franz diffusion cells for assessing drug permeation and skin interactions. The findings highlight the importance of active physical methods, passive nanostructured systems, and chemical penetration enhancers. In conclusion, integrating multiple analytical techniques is essential for the rational design and optimization of effective transdermal drug delivery systems.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia.
ORCID-Profile: Elena O Bakhrushina, Marina M Shumkova, Yana V Avdonina, Mina Babazadeh, Svetlana I Kosenkova, Ivan I Krasnyuk
Zitieren
APA
Bakhrushina, E. O., Shumkova, M. M., Avdonina, Y. V., Ananian, A. A., Babazadeh, M., Pouya, G., Grikh, V. V., Zubareva, I. M., Kosenkova, S. I., Krasnyuk, I. I., & Krasnyuk, I. I. (2025). Transdermal Drug Delivery Systems: Methods for Enhancing Skin Permeability and Their Evaluation. Pharmaceutics, 17(7), 936. https://doi.org/10.3390/pharmaceutics17070936
Vancouver
Bakhrushina EO, Shumkova MM, Avdonina YV, Ananian AA, Babazadeh M, Pouya G, et al. Transdermal Drug Delivery Systems: Methods for Enhancing Skin Permeability and Their Evaluation. Pharmaceutics. 2025;17(7):936. doi:10.3390/pharmaceutics17070936
BibTeX
@article{Bakhrushina2025,
author = {Bakhrushina, Elena O and Shumkova, Marina M and Avdonina, Yana V and Ananian, Arsen A and Babazadeh, Mina and Pouya, Ghazaleh and Grikh, Viktoria V and Zubareva, Irina M and Kosenkova, Svetlana I and Krasnyuk, Ivan I and Krasnyuk, Ivan I},
title = {Transdermal Drug Delivery Systems: Methods for Enhancing Skin Permeability and Their Evaluation},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {7},
pages = {936},
doi = {10.3390/pharmaceutics17070936}
}
EUVIMED